- Jul 2018
-
europepmc.org europepmc.org
-
On 2016 Feb 27, Jim Woodgett commented:
Interested in testing this further in either conditional or global GSK-3 KOs (would also get at possible isoform issue)? We found this approach effective in comparing a different GSK-3 small molecule inhibitor with a GSK-3alpha KO in another model of schizophrenia (DISC1 L100P: http://www.ncbi.nlm.nih.gov/pubmed/20687111). Also rescued behavioural deficits.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Feb 2018
-
europepmc.org europepmc.org
-
On 2016 Feb 27, Jim Woodgett commented:
Interested in testing this further in either conditional or global GSK-3 KOs (would also get at possible isoform issue)? We found this approach effective in comparing a different GSK-3 small molecule inhibitor with a GSK-3alpha KO in another model of schizophrenia (DISC1 L100P: http://www.ncbi.nlm.nih.gov/pubmed/20687111). Also rescued behavioural deficits.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Nov 2016
-
www.sciencedirect.com www.sciencedirect.com
-
A Systems-Level Analysis of the Peripheral Nerve Intrinsic Axonal Growth Program
-